IMU 3.77% 5.1¢ imugene limited

With failures in key commercial cancer drugs in Big Pharma,...

  1. 537 Posts.
    lightbulb Created with Sketch. 208
    With failures in key commercial cancer drugs in Big Pharma, there will be a sense of uncertainty at this conference. Hopefully the new certainty will be Imugene's B-Cell virus range. I'm hoping for CF33 to be approved for testing, soon after the conference.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
-0.002(3.77%)
Mkt cap ! $373.3M
Open High Low Value Volume
5.2¢ 5.2¢ 5.0¢ $669.7K 13.07M

Buyers (Bids)

No. Vol. Price($)
6 1074997 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 1209633 6
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.